Iṣowo ọja, iṣowo owo loni
Awọn abajade iṣura ti awọn ile-iṣẹ 71229 ni akoko gidi.
Iṣowo ọja, iṣowo owo loni

Awọn abajade iṣura

Awọn abajade iṣowo lori ayelujara

Awọn iṣeduro awọn iṣan itan

Iṣowo capital market

Awọn ipinpin owo iṣura

Èrè lati ile-iṣẹ ile-iṣẹ

Iroyin owo

Awọn ifowo iyasọtọ ti ile-iṣẹ. Nibo lati gbewo owo?

Eiger BioPharmaceuticals, Inc. oja fila

Iwọn didun iṣowo ọja Eiger BioPharmaceuticals, Inc. loni ati itan itan-iṣowo ti Eiger BioPharmaceuticals, Inc. lati ibẹrẹ iṣowo ni EIGR ṣe alabapin lori iyipada ọja.
Fi kun ẹrọ ailorukọ
Fi kun si awọn ẹrọ ailorukọ

Eiger BioPharmaceuticals, Inc. capitalization

Loni onipaarọ iṣowo ti Eiger BioPharmaceuticals, Inc. jẹ 50 940 860 US dollar.
+2 214 820 $ (+4.55%)
iyipada ti iṣiparọ-pupọ niwon oṣu

Ayipada kan ni ipo ọja ti Eiger BioPharmaceuticals, Inc. aaye ayelujara wa yiya lo lẹẹkan ni ọjọ kan. Eiger BioPharmaceuticals, Inc. capitalization ti wa ni iṣiro da lori iṣowo lori paṣipaarọ iṣura. Alaye ti agbara-ọrọ ti Eiger BioPharmaceuticals, Inc. jẹ fun itọkasi nikan. Eiger BioPharmaceuticals, Inc. fila ọja loni ni $ 50 940 860.

Eiger BioPharmaceuticals, Inc. iwọn didun ti iṣowo

Loni oni iwọn iṣowo ti Eiger BioPharmaceuticals, Inc. jẹ 133 696 US dollar.
-247 713 $ (-64.95%)
iyipada iwọn didun ti iṣowo lati igba atijọ

Eiger BioPharmaceuticals, Inc. awọn ipele iṣowo loni = 133 696 Awọn dọla AMẸRIKA. Iwe aworan iṣowo ojoojumọ fun Eiger BioPharmaceuticals, Inc. wa lori oju opo wẹẹbu wa. Eiger BioPharmaceuticals, Inc. iṣowo ti o waye lori ọpọlọpọ awọn paṣipaarọ ọja iṣura ni akoko gidi, a fihan iwọn iṣowo ojoojumọ ti Eiger BioPharmaceuticals, Inc.. Eiger BioPharmaceuticals, Inc. gbigbe kapusulu ti pọ ni akawe si lana.

Fihan:
To

Eiger BioPharmaceuticals, Inc. koja apẹrẹ chart

Eiger BioPharmaceuticals, Inc. gbigbe kaakiri lori iwọn kan nipasẹ awọn ọdun. 15.36% ni ọsẹ kan - ayipada kan ni ipo ọja ti Eiger BioPharmaceuticals, Inc.. Eiger BioPharmaceuticals, Inc. iyipada ipin-nla fun ọdun jẹ 0%. Eiger BioPharmaceuticals, Inc., gbigbe kaakiri bayi - 50 940 860 Awọn dọla AMẸRIKA.

Osu Oṣu 3 osu Odun 3 ọdun

Eiger BioPharmaceuticals, Inc. itan akọọlẹ

Ọjọ Ipilẹ agbara
Ipilẹ-iṣowo (iṣowo pataki oja) jẹ iye owo tita gbogbo awọn ile-iṣẹ ti awọn ile-iṣowo ti o ta lori iṣowo ọja. Ipilẹ agbara oja jẹ iwongba ti iye owo awọn iyipo ti o pọ nipasẹ nọmba ti awọn ọja ti o ni iyasọtọ.
03/05/2023 50 940 860 $
02/05/2023 48 726 040 $
01/05/2023 48 916 516 $
28/04/2023 45 041 568 $
27/04/2023 43 663 824 $
26/04/2023 44 599 984 $
25/04/2023 44 158 400 $

Eiger BioPharmaceuticals, Inc. iwọn iwe iwọn didun

Osu Oṣu 3 osu Odun 3 ọdun

Eiger BioPharmaceuticals, Inc. iwọn itan itan-itan

Ọjọ Iwọn didun (24h)
Iwọn iṣowo iṣowo ti Eiger BioPharmaceuticals, Inc. iyatọ ni iye ti gbogbo awọn iṣowo pẹlu awọn EIGR mọlẹbi ti ra ati ta ni ọjọ ti a yan.
03/05/2023 133 696 $
02/05/2023 381 409 $
01/05/2023 197 719 $
28/04/2023 37 149 $
27/04/2023 152 021 $
26/04/2023 111 136 $
25/04/2023 262 813 $

Lori 03/05/2023, Eiger BioPharmaceuticals, Inc. ipin ọja ọja jẹ $ 50 940 860. Eiger BioPharmaceuticals, Inc. kapitalisimu ọja ni 02/05/2023 dogba si 48 726 040 Awọn dọla AMẸRIKA. 01/05/2023 Eiger BioPharmaceuticals, Inc. kapitalisimu ọja jẹ dogba si 48 916 516 Awọn dọla AMẸRIKA. 28/04/2023 Eiger BioPharmaceuticals, Inc. kapitalisimu dogba si 45 041 568 Awọn dọla AMẸRIKA.

Eiger BioPharmaceuticals, Inc. kapitalisimu ọja jẹ $ 43 663 824 ni 27/04/2023. Eiger BioPharmaceuticals, Inc. kapitalisimu ọja ni 26/04/2023 dogba si 44 599 984 Awọn dọla AMẸRIKA. Eiger BioPharmaceuticals, Inc. kapitalisimu ọja ni 25/04/2023 dogba si 44 158 400 Awọn dọla AMẸRIKA.

Awọn capitalitalization ti Eiger BioPharmaceuticals, Inc. loni ni 50 940 860 $. Awọn capitalization oja ti Eiger BioPharmaceuticals, Inc. ti yi pada si +4.55% akawe pẹlu lana. Iwọn iṣowo iṣowo ti EIGR ti Eiger BioPharmaceuticals, Inc. ni ọjọ iṣowo to koja ni 133 696 $. Iwọn iṣowo ti awọn ipinlẹ ti Eiger BioPharmaceuticals, Inc. yipada si -64.947% ti akawe si ọjọ iṣowo iṣaaju.

Awọn iye owo ti awọn mọlẹbi Eiger BioPharmaceuticals, Inc.

Isuna Eiger BioPharmaceuticals, Inc.